E-mail : truthman30@gmail.com

Donation Option..


Click on the paypal Link Below if you’d like to donate.

PayPal-Donate-Button-PNG-File-180x100

 

 

I’ve recently set up a PayPal account and readers have the option of making a donation towards the upkeep of this blog– should they wish to (if not- that’s totally fine too). I got the idea from reading the Guardian website (which also offers a donation option). In the digital age, broadsheet newspapers are finding it difficult to survive, and most now offer a donation option or have a paywall. I don’t expect much in the way of donations to be honest, as my blog isn’t a commercial or mainstream site, however I do believe that the research, writing, blog posts and activism, I have done over a decade here, attest to the work and dedication I have put in.

Writing and blogging, takes time and effort, and I’m proud of the work I have done for over 10 years now. I like to write anyhow, and the stuff I write about needs to be expressed. I get regular hits from the BBC and the Guardian (among many others), and I have certainly covered a wide range of controversial topics in the best journalistic manner I could over the years. I try my best to blog well, and I try to blog about interesting topics not often covered in the mainstream.

The option is there now to donate. Either way, I will continue to blog for as long as my health allows me to. I’ve recently had some health set backs, so I will be taking intermittent breaks to rest and nurture myself. There is usually always something interesting to cover on the blog, and I feel compelled to write most of the time, as it has become a passion of mine. Even if people don’t choose to donate, I will still always very much appreciate people reading, and any kind of support is always humbly appreciated.

Thanks

Even if you don’t donate, I hope you enjoy this beautiful song anyhow!…

 

 

Advertisements

Those GSK Gangster Pharmafioso’s Are At It Again!..


https://www.rte.ie/news/courts/2019/1009/1082127-high-court-swine-flu/

Court hears claims GSK ‘directed and controlled’ HSE over swine flu vaccine

It is claimed that GSK had a liability to Aoife Bennett under the Defective Products Act of 1991
It is claimed that GSK had a liability to Aoife Bennett under the Defective Products Act of 1991

The High Court has heard claims that vaccine makers GlaxoSmithKline “directed and controlled” the Health Service Executive during the procurement process for the Pandemrix vaccine ten years ago.

Lawyers for a woman who says she developed an incurable sleep disorder from the swine flu vaccine said GSK had said certain terms in its contract were non-negotiable and said vaccines ear-marked for Ireland would be given to another country if the terms were not agreed.

Senior Counsel Dermot Gleeson said GSK had anticipated legal action over the Pandemrix vaccine before it was sold to Ireland.

He was continuing an opening statement in the case by Aoife Bennett, a 26-year-old student from Naas Co Kildare, who is suing GSK and the State. Her claims are denied and the case is expected to last ten weeks.

Mr Gleeson said “unusual” contractual clauses insisted upon by GSK showed the pharmaceutical company had anticipated being sued.

The court has heard that GSK insisted on being indemnified by the HSE against any legal action arising from the vaccination programme in 2009.

The court was told that legal correspondence during the procurement process shows some advisers were uncomfortable with the terms being sought by GSK and said they would never agree to them in normal commercial circumstances.

Senior Counsel Dermot Gleeson said the documents showed GSK was also insisting on a clause which meant the HSE could not settle any cases or say anything about it or the vaccine even if it was the right and cost-effective thing to do.

This, he said, amounted to an “unconstitutional agreement” and was “profoundly disquieting” whereby an agent of the State was yielding its power to conduct its own litigation with a citizen of Ireland.

He said the most remarkable clause of the contract was GSK’s insistence that it could give confidential information to the HSE’s lawyers but the HSE would not have access to that information.

“They anticipated litigation and here they were providing detailed arrangements to control the litigation and to control the way in which the barristers were employed by the HSE,” Mr Gleeson said adding: “It lets the cat out of the bag that GSK expected litigation.”

The agreement between the GSK and the HSE amounted to a “constitutional conspiracy” where the rights of a citizen are affected.

Mr Gleeson said the clause required the HSE to subordinate their best constitutionally directed instincts and advice to GSK. “An agent of the State was being directed and controlled bya  foreign pharmaceutical company.”

The case will hear allegations that the Minister and the HSE encouraged vaccination when it was aware the Pandemrix vaccine was not as safe as other vaccines.

It is also claimed the HSE entered into an indemnity agreement with GSK in 2009 as a condition of the company supplying the vaccine.

It is also claimed that the Irish Medicines Board – now the HPRA – wrote to the Department of Health in September 2009 noting there was no safety data available with the swine flu vaccines and no data was yet available from clinical trials which were then underway.

It is claimed that GSK had a liability to Ms Bennett under the Defective Products Act of 1991.

All claims are denied and the defendants will contend the Pandemrix vaccine was properly authorised by the European Commission for use in all EU member states and was required to address the swine flu pandemic.

GSK recalls popular heartburn drug Zantac globally after cancer scare


https://www.euronews.com/2019/10/08/gsk-recalls-prescription-only-versions-of-heartburn-drug-zantac

 

GSK recalls popular heartburn drug Zantac globally after cancer scare

GSK recalls popular heartburn drug Zantac globally after cancer scare

FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo

Copyright

Loriene Perera(Reuters)

Text size Aa Aa

By Justin George Varghese

(Reuters) – GlaxoSmithKline <GSK.L> on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution”, days after the U.S. Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug.

Zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year.

Britain’s medicines watchdog said GlaxoSmithKline (GSK) was recalling four prescription-only Zantac medicines: a syrup, an injection and tablets of 150 and 300 milligram (mg) dosages. (https://bit.ly/2IATooO)

Over-the-counter 75 mg dosage Zantac products are produced by a different company and are not affected by the recall, it added.

GSK informed the MHRA of our decision to suspend the release, distribution and supply of all dose forms of Zantac products,” a company spokesman confirmed to Reuters.

GSK is continuing with investigations into the potential source of the NDMA,” he said, adding that the investigations include continued engagement with its suppliers and with external laboratories to conduct tests on finished product batches of Zantac.

The Medicines and Healthcare products Regulatory Agency (MHRA) said healthcare professionals were told on Monday to “stop supplying the products immediately, quarantine all remaining stock and return it to their supplier”.

“We are advising that patients should not to stop taking their medication, and do not need to see their doctor until their next routine appointment but should seek their doctor’s advice if they have any concerns,” the MHRA said.

GLOBALSTOPPAGE

U.S. and European health regulators said last month they were reviewing the safety of ranitidine, after online pharmacy Valisure flagged the impurities.

The FDA said Valisure’s higher-temperature testing method generated very high levels of NDMA from the ranitidine drugs.

NDMA had previously been found in some blood pressure medicines from a class of drugs known as angiotensin II receptor blockers, or ARBs.

After checking the over-the-counter drugs using a low-heat method of testing, the FDA said it found much lower levels of NDMA than was discovered with a higher temperature test employed by Valisure.

The U.S. regulator has asked ranitidine makers to conduct their own testing to assess levels of the impurity and to send samples of their products for testing by the agency.

Swiss drugmaker Novartis <NOVN.S> halted global distribution of its ranitidine drugs last month.

Last week, Walmart Inc <WMT.N> joined pharmacy chains CVS Health Corp <CVS.N>, Walgreens Boots Alliance Inc <WBA.O> and Rite Aid Corp <RAD.N> in suspending the sale of over-the-counter heartburn drugs containing ranitidine.

Canada’s health authorities have asked makers of the drugs to halt distribution as they gather more information. Last month, regulators in Hong Kong pulled four products, while in Ireland 13 products containing ranitidine were recalled.

The impurity was believed to have been introduced by changes in the manufacturing process.

(Reporting by Justin George Varghese in Bengaluru; Editing by Deepa Babington, Mark Potter and Dan Grebler)

GSK recalls ranitidine medication globally


Interesting news brewing about GSK’s possible ‘cancer causing’ med ranitidine (also known as Zantac). How many millions of people over many years have ingested this crap?

How many has it harmed?

GSK’s manufacturing process is not fit for purpose..

It’s harming people..

https://truthman30.wordpress.com/2018/06/23/thomas-reilly-versus-glaxosmithkline-glaxos-manufacturing-processes-are-not-fit-for-purpose/


https://www.businesstoday.in/sectors/pharma/gsk-recalls-ranitidine-medication-globally/story/381279.html

 

GSK has decided to voluntarily recall its ranitidine medication sold in global markets including India as a precautionary action pending the outcome of ongoing tests and investigations globally. Business Today gathers that ranitidine is a Rs 200 crore brand in India and accounts for roughly 9 per cent of GSK pharma sales in India.

This move follows the US regulator’s caution note issued on September 13 alerting patients and health care professionals that NDMA was found in samples of ranitidine. NDMA, the US regulator explained “is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.”

GSK spokesperson informs that the company has been contacted by the regulatory authorities of different countries, including India, regarding the detection of genotoxic nitrosamine NDMA in ranitidine products. “Based on the information received and correspondence with regulatory authorities GSK made the decision to suspend the release, distribution and supply of all dose forms of ranitidine hydrochloride products to all markets, including India, as a precautionary action pending the outcome of ongoing tests and investigations.”

A note issued by GSK says, subsequent to its decision, Saraca Laboratories, the company in India that supplies APIs for this, has been notified by the European Directorate for the Quality of Medicines (EDQM) that its certificate of suitability for ranitidine hydrochloride has been suspended with immediate effect.

GSK manufactures Ranitidine Hydrochloride IP Tablets 150 mg and 300 mg (Zinetac) using API from Saraca Laboratories and another supplier, SMS Lifesciences India, for supply to Indian market.

As a precautionary action, GSK has decided to initiate voluntary recall (pharmacy/retail level recall) of Zinetac Tablets 150 mg and 300 mg products manufactured in India using API sourced from Saraca Laboratories Limited.

“The product manufactured using API from SMS will not be recalled from the market at this point of time. However, all such products will remain on hold and will not be released while we await test results,” a note from the company says.

GSK, it says, “is continuing investigations into the potential source of the NDMA. These investigations include continued engagement with our API suppliers. Patient safety remains our utmost priority and we are taking this issue very seriously.”


800px-Zantac

Various Countries Move To Suspend Imports Of (GSK manufactured) Zantac Med…


https://www.everydayhealth.com/heart-health/what-you-need-know-contaminants-found-zantac/

“…..Sandoz, a division of Novartis AG, announced on September 18 that it would stop worldwide distribution of all ranitidine-containing medicines, including brand-name and generic Zantac, because of potential impurities in the heartburn medication.

This new decision came a few days after the U.S. Food and Drug Administration (FDA) released a statement alerting healthcare professionals and consumers that low levels of the probable human carcinogen N-nitrosodimethylamine (NDMA) was found in some ranitidine medicines, including Zantac.

“The FDA is continuing to investigate how long NDMA has been present in ranitidine and will communicate information on the risk to patients as it becomes available,” an FDA spokesperson, Jeremy Kahn, told Everyday Health.”…


Further to my post recently on Zantac- the GSK heartburn med- it seems that some countries are banning it altogether in light of the news that the medication can cause cancer.

It is interesting to note that GSK traded Zantac in a merger/swap deal with Novartis some years ago. Whether GSK knew of this carcinogen before this, or before it went generic is anyone’s guess, but in light of their reputation, it is entirely possible that they did isn’t it?

It’s interesting to note that GSK retained the rights to manufacture Zantac after it sold rights to Zantac to other Pharma companies. Whether this latest GSK scandal has anything to do with the fact that GSK’s manufacturing and IT systems are not fit for purpose (see here, here, and here), and that they have had a staggering history of drug recalls to further illustrate it- is not known for sure at this point, however many news outlets are now reporting on Zantac, and it will be interesting to see how this all unfolds…

 

See Articles below :


 

 

“…..The drugs that GSK put on the block, known as established products, are expected to have combined 2014 sales of around 1 billion pounds($1.6 billion) but their sales are in long-term decline due to competition from cheaper generics.

They included antidepressant Paxil, migraine treatment Imitrex, Zantac for stomach acid and Zofran for nausea. The company always intended to retain the rights to such products in emerging markets, where they are still growing.

GSK Chief Executive Andrew Witty, who plans to close a major asset-swap deal with Novartis next year, is under pressure to deliver value to investors after a period of lacklustre performance…..”

https://www.reuters.com/article/us-gsk-m-a-established-products/glaxosmithkline-drops-plan-to-sell-off-older-drugs-business-idUSKCN0JI1WK20141204

 

Swiss specialist pharmaceutical firm Covis Pharma has acquired full commercial rights to GlaxoSmithKline’s Fortaz (ceftazidime), Zinacef (cefuroxime), Lanoxin (digoxin), Parnate (tranylcypromine sulfate), and Zantac Injection (ranitidine hydrochloride) in the US and Puerto Rico.

GSK will retain the existing rights for these products in countries outside the US. Terms of the agreement have not been disclosed.

‘We are very pleased to announce the acquisition of this portfolio of drugs as we establish Covis as a leading specialist pharmaceutical company,’ said Jack Davis, chief executive of Covis Pharma, which is headquartered in Zug.

‘Our management team looks forward to building out our platform beyond the current focus on the acute care, cardiovascular and CNS markets, into new and adjacent therapeutic areas.’

Covis Pharmaceuticals Inc (USA), a Raleigh, North Carolina-based affiliate will provide US sales and distribution support to Covis Pharma.

GSK will manufacture and supply Fortaz Injection, Zinacef Injection, Parnate, and Zantac Injection to Covis. Lanoxin Tablets and Injection, Fortaz Frozen, Zinacef Frozen and Zantac Injection Premixed will continue to be manufactured and supplied by current third-party suppliers.

https://www.manufacturingchemist.com/news/article_page/Covis_Pharma_gains_rights_to_certain_GSK_drugs_in_US_and_Puerto_Rico/72276


 

GSK.png

 

https://www.zawya.com/mena/en/legal/story/Bahrain_suspends_registration_import_and_distribution_of_all_medicines_containing_ranitidine-SNG_154842769/

 

Bahrain suspends registration, import and distribution of all medicines containing ranitidine

Move was a precautionary measure

A Palestinian pharmacist arranges medicines in a pharmacy in Hebron, in the occupied West Bank May 23, 2018. Image used for illustrative purposes.

A Palestinian pharmacist arranges medicines in a pharmacy in Hebron, in the occupied West Bank May 23, 2018. Image used for illustrative purposes.

Mussa Qawasma – RC1F1C67FB50

Bahrain has temporarily suspended registration of popular medications used to treat digestive problems following concerns they may contain a cancer-causing chemical.

Following steps taken by the UAE’s Health and Prevention Ministry, Bahrain yesterday announced suspending the registration, importing and distribution of all medicines containing ranitidine.

National Health Regulatory Authority (NHRA) chief executive Dr Maryam Al Jalahma told the GDN yesterday that the move was a precautionary measure.

She added that any potential withdrawal will only be done after global health regulators reveal the findings of an investigation into the drugs.

The GDN reported last week that ranitidine, a medication widely known by its brand name Zantac and generic alternatives Navidine and Histac, could contain small amounts of a cancer-causing chemical called N-nitrosodimethylamine (NDMA).

“No new registrations will be issued for the drug until we check the results of the laboratory analysis,” said Dr Al Jalahma.

“Regarding the drugs that are in the market, we are waiting for the analysis of those as well, which is being conducted in Saudi Arabia as well as in the UAE.

“Based on the results we will take the decision on which brand or batch is to be withdrawn and which are to be retained in the market.”

GSK Manufactured Med- Zantac -Has Cancer Causing Ingredient..


Ranitidine-150mg-Tabs-Zantac

 

https://eu.usatoday.com/story/money/2019/09/19/generic-zantac-ranitidine-sandoz-distribution-stop-novartis/2372161001/

“….A division of Swiss pharmaceutical maker Novartis is halting distribution of generic Zantac pills over concerns about an ingredient possibly linked to cancer.

http://www.taipeitimes.com/News/front/archives/2019/09/20/2003722601

The Ministry of Health and Welfare yesterday said that it is launching an investigation into stomach medicine containing ranitidine, which is marketed under the trade name Zantac, after a tip-off from the US Food and Drug Administration and the European Medicines Agency that it might contain a carcinogenic substance.

The ministry had been advised that Zantac, which is manufactured by UK-based GlaxoSmithKline PLC, could contain traces of N-Nitrosodimethylamine (NDMA),

https://www.regulainspection.com/ndma-contamination-in-zantac/?lang=en

NDMA contamination in Zantac

“….Low levels of a ‘potentially dangerous’ cancer-causing chemical has been found in Zantac, a popular drug that treats heartburn.

It’s N-nitrosodimethylamine, better known as NDMA. It’s been classified as a probable human carcinogen because laboratory tests indicated it could potentially cause cancer, particularly tumors in the liver and other organs.

You may remember NDMA because it’s the same nitrosamine impurity that was found in Valsartan, the blood pressure medication that had widespread recalls last year….”


 

There has been a series of articles in the media recently about GSK’s Zantac (heartburn) med and a link to a cancer causing ingredient. Many countries are now starting to warn about this, and there have been recalls. As far as I am aware, GSK traded Zantac with Novartis as part of their merger deal (see here) a few years ago, but it seems (according to the article above) that GSK still manufacture it.

Were GSK aware that Zantac has these cancer causing problems when they did the deal? and if so what are the implications of this? Furthermore it’s interesting to note that Zantac was considered the world’s best selling drug in 1994 with a whopping $2.4 Billion in sales. It seems that Zantac was also part owned by Wellcome before GSK also took over some of that business (see here). In 2016 it was estimated that Zantac was the 50th most prescribed drug in the world, therefore it’s incredible to think that millions upon millions of people have likely been exposed to some kind of carcinogen without their knowledge.

There are many questions to be answered here in this latest GSK scandal, not least concerning GSK’s dodgy manufacturing processes which I have been drawing attention to over the past year (see here and here).

Has Zantac always had this cancer causing ingredient? or has this cancer causing ingredient happened because of GSK’s dodgy manufacturing processes- through some kind of contamination at the production level?

Just the other week, a new whistle-blower contacted me verifying my recent posts about GSK’s dodgy IT systems and manufacturing processes. This whistle-blower is also concerned that there are  :

” …Serious security exposures across Glaxos global computers and breakdown of internal controls created a situation where users can bring down computers and change electronic data. People in Glaxo businesses brought this to attention of management but the information continues to be suppressed and withheld from the public….”

Anonymous GSK WhistleBlower 19/09/2019

 

How many people have GSK harmed with defective, dangerous and contaminated medications over the decades? How many people are involved in this cover up?

The potential harm (current, past and future) to the public is immense.

Will any journalists join the dots and do some coverage of this? or is it perpetually up to bloggers like me to constantly bring attenton to these GSK scandals, like I have been doing for over a decade now on my blog?

For an extensive (but by no means complete) list of GSK recalls over the years (which I researched and correlated myself) see the following link, and perhaps ask yourself to question- is any GSK medication or product safe to take?

Personally, I don’t think that they are…

https://truthman30.wordpress.com/2018/06/23/thomas-reilly-versus-glaxosmithkline-glaxos-manufacturing-processes-are-not-fit-for-purpose/

How can the ‘best selling drug in history” (with Cancer causing properties?) be on the market for so long  without regulators realizing the risks?

 


https://www.ncbi.nlm.nih.gov/pubmed/10169076

 

How Zantac became the best-selling drug in history.

Abstract

Glaxo’s Zantac began its dominance of the acid/peptic marketplace with a launch strategy, taking advantage of the established Roche sales force to rapidly promote the product. Educational symposia for physicians were instrumental in disseminating both disease and product information to primary care physicians and specialists. This technique not only pleased physicians (more referrals), but also increased public awareness of gastrointestinal disease, further expanding the patient market. Several novel marketing strategies contributed to Zantac’s success, including the public-service announcements, celebrity media tours, and consumer-awareness bulletins, which brought the drug to the lay public and encouraged individuals to seek advice from their physicians.

 

 

 

 

 

 

 

A Message From A New GSK WhistleBlower…


“…..Serious security exposures across Glaxos global computers and breakdown of internal controls created a situation where users can bring down computers and change electronic data. People in Glaxo businesses brought this to attention of management but the information continues to be suppressed and withheld from the public….”

Anonymous GSK WhistleBlower 19/09/2019


Seems that there’s more GSK whistle-blowers out there.

I got an attachment in my e-mail in my inbox today which backs up the authenticity of the blog posts I have done about GSK’s dodgy manufacturing and IT processes.

GSK have been covering up that their manufacturing processes are not fit for purpose (this scandal is also putting millions of people’s lives at risk every day, year upon year – for decades)

GSK’s drug recalls over the years are staggering. (see here)

Why would this be?

Why do GSK have so many drug recalls? recalls ranging from splinters in millions of tubes of toothpaste, to asbestos contamination in various drugs. (see Cidra here)

It’s simply because GSK’s IT processes are broken, and the upper management are ignoring it, and covering it up.

Thanks to this new Whistleblower for getting in touch.

I hope there is more to come…

 

FullSizeRender.jpg

Seroxat : ….”You can’t come off it… that’s the problem”..


http://antidepaware.co.uk/news-and-comment/

 

September 8 2019

On January 15th this year, on the eve of his 42nd birthday, DJ Jackson Cummings (right) jumped to his death from a multi-storey car park in Newcastle-under-Lyme, Staffordshire.

At his inquest in Stoke-on-Trent on Thursday, Jackson’s family blamed the SSRI antidepressant Seroxat for his death.

The court heard that, in the months beforehand, Jackson had scoured the Internet for cases of other people on Seroxat who were experiencing adverse symptoms. He had been taking the drug for 21 years, since he was prescribed it for anxiety while at university, but felt it was no longer working and wanted to give it up. His mother Viv said: The effects had started to be worse than his anxiety. But you can’t come off it – that’s the problem.”

Jackson, who had been diagnosed with Seasonal Affective Disorder (SAD), had a longstanding habit of altering the amount of medication he took without consulting doctors. His last contact with mental health services was the day before his death when he confided to having intermittent suicidal thoughts, but had no plans to act on them. He agreed to stay on his medication and was due to be assessed again in a few weeks.

Jackson’s family told the inquest that he had hardly slept for days, with his mother adding: “He was un-showered and unkempt, with a deep sense of hopelessness.”

Jackson’s father Tony raised their concerns about Seroxat, pointing out that it was banned for use by adolescents in the US. He said: “I just don’t want anybody else to go through what we’ve been through. This Seroxat must be stopped.”

Seroxat featured in a number of high-profile inquests and court cases, both in the UK and in the USA, in the earlier part of this century. Consequently, it is now prescribed very infrequently.

Even so, psychiatrist Dr Haroon Rashid, who saw Jackson the day before his death, told the inquest that there was “no evidence” that the antidepressant triggered suicidal ideation in adults.

North Staffordshire coroner Andrew Barkley (left) chose not to challenge this erroneous statement. Recording a conclusion of suicide, he said that it was a “concern” that Jackson was “making his own adjustments” to his medication. He added: “That is a significant risk in that it can give rise to a relapse.”

Family Of DJ, Jackson Cummings,Who Jumped To His Death, Say Seroxat Caused His Suicide…


“….In the months beforehand, he’d scoured the internet for cases of other people on the anti-depressant Seroxat who were experiencing adverse symptoms…”

Jackson’s father Tony raised their Seroxat concerns at the inquest, pointing out it was banned for use by adolescents in the US.

‘I just don’t want anybody else to go through what we’ve been through’

Mr Cummings said: “I just don’t want anybody else to go through what we’ve been through. This Seroxat must be stopped.”

https://www.stokesentinel.co.uk/news/stoke-on-trent-news/i-dont-want-anyone-go-3289395

 

 

My heart goes out to this guy. He didn’t need to die. Seroxat should have been banned decades ago, it should never have been licensed in the first place. GSK (the Seroxat manufacturers) are an abhorrent company

Jackson was the same age as me, the only difference is I came off Seroxat after 3 years, whereas he stayed on it for 21 years. How he withstood the side effects for that long is staggering. It must have been so hard for him, I can only imagine how difficult his life must have been

For me, Seroxat was hell for those 3 years, I cannot even fathom 21 years on that poison.

I hope Jackson is at peace now.


https://www.mirror.co.uk/news/uk-news/family-dj-who-jumped-multi-19877870

 

Family of DJ who jumped from multi-storey car park say medication caused suicide

Jackson Cummings took his life in Newcastle-under-Lyme, Staffordshire, one day before his 42nd birthday, an inquest heard

Jackson Cummings, 41, jumped to his death from a multi-storey car park

Get the biggest daily news stories by email

The family of a troubled DJ who jumped to his death from the top of a multi-storey car park fear his medication may have triggered suicidal thoughts, an inquest has heard.

In the months before his death, Jackson Cummings, 41, had scoured the internet for cases of other people on the anti-depressant Seroxat who were experiencing adverse symptoms.

His inquest on Friday heard he had been taking the drug for 21 years but the “effects had started to be worse than his anxiety” and he wanted to give it up.

And on the eve of his 42nd birthday, the DJ took his own life at a car park, Stoke-on-Trent Live reports today.

Speaking at the inquest, Jackson’s heartbroken mum Viv said: “The effects had started to be worse than his anxiety. But you can’t come off it – that’s the problem.”

Jackson Cummings, 41, jumped to his death from a multi-storey car park

 

The hearing was told Jackson suffered from seasonal affective disorder (SAD) and had a longstanding habit of altering the amount of medication he took without consulting doctors.

The inquest was told there was a ‘possibility’ his decision to wean himself off Seroxat placed him at increased risk of suicide.

It emerged Jackson had not asked doctors if he could come off the drug.

The evidence led to North Staffordshire coroner Andrew Barkley recorded a conclusion of suicide and said it was a ‘concern’ that Jackson was ‘making his own adjustments’ to his medication.

“That is a significant risk in that it can give rise to a relapse,” he said.

Jackson, of Trentham, Stoke-on-Trent, told mental health services of his intermittent suicidal thoughts, but had no plans to act on them. He agreed to stay on his medication and was due to be assessed again in a few weeks.

The family, who shared photos taken before the DJ’s funeral, shared their heartbreak

 

 

Seroxat Withdrawal And Suicide..


“….Antony Schofield <aschofield@runbox.com>
Sun, Aug 25, 11:05 AM

Dear Dr Gordon,

I have been suffering from extremely severe withdrawal symptoms from the anti-depressant drug paroxetine for over six months now. These symptoms include but are not limited to: body and head jerking, severe agitation, hyperventilation to the point of passing out, and waves of “toxic depression”…..”


In the 13 years that I have been writing this blog, and the 15 years since I took my last Seroxat pill, I have come across countless stories of Seroxat (and other SSRI) induced damage, death and destruction. Of course, there are some people who take SSRI’s and claim that these drugs helped them, or that the drugs are worth the risks, or that they know the risks and are willing to bear them because they want to take the drugs etc; of course those people exist: and they exist in large numbers. However there is an equally large demographic of people who also feel that these drugs made them worse, or harmed them, or their family members, and there’s even many cases where it is obvious that the drugs have led to tragic deaths.

Antony is one of those cases.

Antony Schofield contacted Dr Peter Gordon (a psychiatrist who has been very vocal about his own Seroxat induced suicidality and other related matters on his blog, and in the media). He expressed how his Seroxat withdrawals and symptoms were driving him to the edge of utter despair. I can relate to all of Antony’s Seroxat withdrawal symptoms. I am lucky that I survived it, and I barely did. It is eerily familiar to read of Antony’s plight, even though I came off Seroxat a long time ago. Seroxat simply should never have made it to market, it was never a safe drug to begin with, and it’s arguable that in today’s world it wouldn’t be licenced- period. Myself, Bob Fiddaman, and other bloggers, have been shouting from the rooftops about all this for over a decade; we took the drug, we experienced the horrors. Peter Gordon, an experienced and well respected- psychiatrist, has also experienced the Seroxat horror, and it was his brave article in the daily Mail that brought Antony to Peter’s blog.

Tragically, Antony recently killed himself in Seroxat withdrawal.

Unfortunately, the Royal College of Psychiatry UK, and mainstream bio-logical psychiatry in general, is more concerned with the reputation of the psychiatric drugs that they prescribe, than cases like Antony’s or cases like mine, or the many hundreds of thousands of other cases of SSRI induced harm documented all over the internet, and elsewhere.

The Royal College is complicit in a cover up about these drugs, and many of these psychiatrists have been defending the drugs, and vilifying patients who criticize them for years. Many of these psychiatrists have also been paid by drug companies. Mainstream psychiatry is corrupt to the core.

This fiasco must stop.

A comment on Twitter from the Royal College of psychiatry president Wendy Burn kinda sums up the college’s attitude towards those harmed. The sheer ignorance, nonchalance, and utter offensiveness of Wendy’s tweet is mind-boggling.

 

Wendy


From Dr Peter Gordon’s blog

https://holeousia.com/2019/09/04/antony/

Antony

A week before he took his life, Antony Schofield e-mailed me:

Antony Schofield <aschofield@runbox.com>
Sun, Aug 25, 11:05 AM

Dear Dr Gordon,
I have been suffering from extremely severe withdrawal symptoms from the anti-depressant drug paroxetine for over six months now. These symptoms include but are not limited to: body and head jerking, severe agitation, hyperventilation to the point of passing out, and waves of “toxic depression”.

I admitted myself to hospital after a failed attempt to take my own life. They discharged me after 10 days as there was nothing they could do for/with me and I was becoming a burden on the nurses and the other patients.

Every second of my waking existence is horrific. I have repeatedly expressed my wish to die with dignity as I am now unable to maintain even the most basic standards of personal hygiene. I have socially isolated to the extreme as my condition makes associating with people impossible.

In my desperate state I have contacted the British group “My Death My Decision” as well as the group “Exit International” so they will have a record of my experience even though there is nothing they can do to help me.

You have my permission to share my correspondence with anyone you deem to be appropriate.

Yours sincerely,
Antony Schofield


https://holeousia.com/2019/09/04/antonys-mother/

 

Last week, Antony contacted me. He was in great distress. I replied straight away.

This week, Antony’s mother contacted me to tell me that Antony was dead.

[Antony’s mother is in her eighties. Antony was her only son. Since Antony’s death we have spoken on the phone. Antony’s mother is now bereaved, isolated and alone]

[I shared my communications with Antony, along with confirmation of his death by suicide, with the President of the Royal College of Psychiatrists. I have received no reply from the President or any other spokesperson from the Royal College]

Please note: Antony's mum has given me full consent to write about the final day's of her only son. Indeed she has asked me to do so, adding that I was "the only one to believe in her son" and his most distressing, and ultimately overwhelming symptoms of withdrawal from a prescribed medication.

GSK Failing To Warn Of Risks Of Their Drugs Seems To Be A Habit-Forming Thing For Them…


 

A federal judge overseeing hundreds lawsuits by women who claim the anti-nausea drug Zofran causes birth defects and that GlaxoSmithKline PLC failed to warn of its risks on Wednesday said the first trial nationally would take place in January.

U.S. District Judge F. Dennis Saylor in Boston set the Jan. 13 date for the bellwether case after previously pushing back what was to be a September trial so he could hear new arguments about whether federal law preempts the women’s state law claims.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2Z18Wb3

dralisonbarrett

the ecosystem approach to obgyn

My Life in my 60's

Finding joy in my 60's

The Vile Mint

Poetry, Short Stories and Violent Ideas

POSITIVELY HERE

"HAVE NO FEAR OF PERFECTION, YOU'LL NEVER REACH IT" - Salvador Dali

Rebel City Writers

A radical perspective on local, national and international issues from the pens of a few disgruntled agitators!

Critical Dispatches

Reports from my somewhat unusual life

~ L to the Aura ~

sustainability. compassion. inspiration.

Heroes Not Zombies

becoming not being.......

DES Daughter Network

Because Social Media increases Awareness and brings the DES Community Together

recovery network: Toronto

people can and do recover from what is sometimes called "mental illness"

Deidra Alexander's Blog

I have people to kill, lives to ruin, plagues to bring, and worlds to destroy. I am not the Angel of Death. I'm a fiction writer.

%d bloggers like this: